Irireos Antistaminico (Cetirizine Dihydrochloride)

Cetirizine works by selectively blocking peripheral H1 histamine receptors. This inhibition prevents histamine from binding to its receptors, thereby reducing the vascular and sensory effects that cause itching, swelling, and nasal discharge during allergic reactions.

The appropriate dose of Irireos Antistaminico is determined by a qualified healthcare professional based on the patient’s age, weight, renal function, and the severity of symptoms. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare provider before using Irireos Antistaminico.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irireos Antistaminico (cetirizine) is a second‑generation antihistamine that typically causes less sedation than first‑generation agents like diphenhydramine. It offers a rapid onset of action and a once‑daily dosing schedule, making it convenient for managing allergic symptoms.

Store Irireos Antistaminico at ambient temperature below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Irireos Antistaminico is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber.

Serious adverse reactions, although rare, include anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like rash, swelling, difficulty breathing, or jaundice.

Individuals with known hypersensitivity to cetirizine or any component of the formulation should avoid using Irireos Antistaminico. Caution is also advised for patients with severe renal impairment, as dose adjustment may be required.